Merck IDO1 inhibitor

heme-displacing IDO1 inhibitor

human predicted QD dose of 26 mg

from 260k MS-based screen and SBDD

ACS Med. Chem. Lett. Mar. 10, 2020

Merck, Boston, MA

Merck IDO1 inhibitor (Merck heme-displacing oral IDO1 inhibitor)

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.